Clinical Trials Logo
  1. Home
  2. Refractory Angina Pectoris
  3. NCT01567592

Extracorporeal Shockwave Therapy for the Treatment of Chronic Angina Pectoris

Refractory Angina Pectoris Clinical Trial

Official title:
Clinical Trial Evaluating the Treatment of Patients With Refractory Angina Pectoris With Low Intensity Extracorporeal Shockwave Therapy Device

Clinical Trial Summary

Low intensity shockwaves have been proven in animal studies to induce local growth of new blood vessels from existing ones.

The hypothesis of this study is that shockwave therapy could improve the symptoms of patients with refractory angina not amenable to revascularization with angioplasty or bypass surgery.

Clinical Trial Description

Low intensity shockwaves (1/10 the ones used in Lithotripsy) are delivered to myocardial ischemic tissue. Shockwaves are created by a special generator and are focused using a shockwave applicator device. The treatment is guided by standard echocardiography equipment. The shockwaves are delivered in synchronization with Patient R-wave to avoid arrhythmias. The treatment is painless.

At first, the patient undergoes stress- SPECT testing to identify the ischemic areas. Following that, the same area is localized by the ultra-sound device and the shockwaves are focused to the ischemic area. Several treatments are required for optimal results. ;

Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01567592
Study type Interventional
Source Medispec
Contact
Status Suspended
Phase Phase 1
Start date March 2009
Completion date December 2012
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT03438500 - Cardiac Shock Wave Treatment in Patients With Reduced Coronary Flow Reserve N/A
Recruiting NCT01711099 - Efficacy of Extracorporeal Shockwave Myocardial Revascularization N/A
Active, not recruiting NCT03039751 - Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angina Pectoris Phase 2
Recruiting NCT05711849 - Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina Phase 2
Active, not recruiting NCT01241968 - Extracorporeal Shock Wave Therapy for the Treatment of Ischemic Heart Disease Phase 2
Recruiting NCT02499250 - Effect of Daily Remote Ischemic Conditioning on the Life Quality of Refractory Angina Pectoris Patients N/A
Completed NCT01219218 - Extracorporeal Shockwave Therapy for the Treatment of Advanced Angina Pectoris Phase 1
Active, not recruiting NCT01567644 - Extracorporeal Shockwave Therapy for the Treatment of Refractory Chronic Angina Pectoris Phase 1
Completed NCT00662727 - Extracorporeal Shockwave Therapy for the Treatment of Refractory Angina Pectoris Phase 2
Completed NCT04121845 - CoROnary SinuS Reducer implantatiOn for ischemiA reDuction N/A
Active, not recruiting NCT05174572 - IMR Evaluation in Patients With Coronary Sinus Reducer Implantation (INROAD Study) N/A
Recruiting NCT04915157 - Efficacy of Spinal Cord Stimulation in Patients With Refractory Angina Pectoris N/A
Completed NCT01508910 - Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina Phase 3